Showing results (321-330 of 385) with videos related to

Sort By:
Pageof 39
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 23, 2013
Emerging evidence on the pathobiology of mucositisNoor Al-Dasooqi, Stephen T Sonis, Joanne M Bowen, et al.
Obstetrics and Gynecology|August 21, 2025
Maternal Human Immunodeficiency Virus and Preeclampsia Among a Combined Cohort of Zambian WomenKatelyn J Rittenhouse, Margaret P Kasaro, M Bridget Spelke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 12, 2013
Emerging evidence on the pathobiology of mucositisNoor Al-Dasooqi, Stephen T Sonis, Joanne M Bowen, et al.
AIDS (London, England)|August 30, 2008
Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, ZambiaLloyd B Mulenga, Gina Kruse, Shabir Lakhi, et al.
Endocrinology|March 7, 2022
Inhibin Inactivation in Female Mice Leads to Elevated FSH Levels, Ovarian Overstimulation, and Pregnancy LossKelly L Walton, Monica P Goney, Zoe Peppas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 9, 2017
Fractionated abdominal irradiation induces intestinal microvascular changes in an in vivo model of radiotherapy-induced gut toxicityRomany L Stansborough, Emma H Bateman, Noor Al-Dasooqi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 14, 2018
Matrix metalloproteinase expression is altered in the small and large intestine following fractionated radiation in vivoRomany L Stansborough, Noor Al-Dasooqi, Emma H Bateman, et al.
International Journal of Radiation Biology|June 2, 2018
Vascular endothelial growth factor (VEGF), transforming growth factor beta (TGFβ), angiostatin, and endostatin are increased in radiotherapy-induced gastrointestinal toxicityRomany L Stansborough, Emma H Bateman, Noor Al-Dasooqi, et al.
The Lancet. Oncology|March 28, 2024
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b studyRachel M Layman, Hyo S Han, Hope S Rugo, et al.
The British Journal of Dermatology|April 23, 2002
Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology GroupColin A Morton, S B Brown, S Collins, et al.
Pageof 39